Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors

 

 Buy Article Permissions and Reprints

Abstract

Phytochemical investigation of the soil microfungus Eupenicillum parvum led to the isolation of two new compounds: a chromone derivative euparvione (1) and a new mycophenolic derivative euparvilactone (2), as well as thirteen known compounds. The structures of the new compounds were elucidated by means of extensive IR, NMR, and MS data and by comparison of data reported in the literature. The structure of the known compound 6 was confirmed by X-ray crystallography. Several isolated compounds were evaluated for in vitro binding assays using opioid receptors (subtypes δ, κ, and µ) and cannabinoid receptors (CB1 and CB2). Compound 10 displayed the best selective µ-opioid receptor and CB1 receptor binding affinities showing values of 47 % and 52 % at a 10 µM concentration, respectively. These findings provide insight into the potential therapeutic utility of this class of compounds.

• References

• 1 Bushlin I, Rozenfeld R, Devi LA. Cannabinoid–opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol 2010; 10: 80-86
  CrossrefPubMedGoogle Scholar
• 2 Gao J, Radwan MM, León F, Dale OR, Husni AS, Wu Y, Lupien S, Wang X, Manly SP, Hill RA, Dugan FM, Cutler HG, Cutler SJ. Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoids receptors. J Nat Prod 2013; 76: 824-828
  CrossrefPubMedGoogle Scholar
• 3 Habib E, León F, Bauer JD, Hill RA, Carvalho P, Cutler HG, Cutler SJ. Mycophenolic derivatives from Eupenicillium parvum . J Nat Prod 2008; 71: 1915-1918
  CrossrefPubMedGoogle Scholar
• 4 Haishi T, Furuya K, Nakajima M, Kinoshita T, Kagazaki T, Sakaida Y. Novel antibiotic phthalexin and its manufacture with Eupenicillium parvum.. JP Patent 01290667, 1989
  PubMedGoogle Scholar
• 5 Kusari S, Verma VC, Lamshoeft M, Spiteller M. An endophytic fungus from Azadirachta indica A. Juss that produce azadirachtin. World J Microbiol Biotechnol 2012; 28: 1287-1294
  CrossrefPubMedGoogle Scholar
• 6 Capon RM. Derivatives of mycophenolic acid. Aust J Chem 1978; 31: 353-364
  CrossrefPubMedGoogle Scholar
• 7 Covarrubias-Zuñiga A, Gonzalez-Lucas A, Dominguez MM. Total synthesis of mycophenolic acid. Tetrahedron 2003; 59: 1989-1994
  CrossrefPubMedGoogle Scholar
• 8 Jones DF, Mills SD. Preparation and antitumor properties of analogs and derivatives of mycophenolic acid. J Med Chem 1971; 14: 305-311
  CrossrefPubMedGoogle Scholar
• 9 Danheiser RL, Gee SK, Perez JJ. Total synthesis of mycophenolic acid. J Am Chem Soc 1986; 108: 806-810
  CrossrefPubMedGoogle Scholar
• 10 Jones DF, Moore RH, Crawley G. Microbial modification of mycophenolic acid. J Chem Soc (C) 1970; 1725-1737
  CrossrefPubMedGoogle Scholar
• 11 Fujimoto H, Fujimaki T, Okuyama E, Yamazaki M. Immunomodulatory constituents from an ascomycete Microascus tardifaciens . Chem Pharm Bull 1999; 47: 1426-1432
  CrossrefPubMedGoogle Scholar
• 12 Kashiwada Y, Nonaka G, Nishioka I. Studies on Rhubarb (Rhei Rhizoma). Isolation and characterization of chromone and chromanone derivatives. Chem Pharm Bull 1984; 32: 3493-3500
  CrossrefPubMedGoogle Scholar
• 13 Yamauchi M, Katayama S, Watanabe T. Studies on the syntheses of heterocyclic compounds containing benzopyrone. Part 6. Biomimetic total synthesis of citromycetin. J Chem Soc [Perkin I] 1987; 395-398
  PubMedGoogle Scholar
• 14 DeSimone F, Senatore F, Sica D, Zollo F. Sterols from basidiomycetes. Phytochemistry 1979; 18: 1572-1573
  CrossrefPubMedGoogle Scholar
• 15 Abraham WR, Schmeda-Hirschmann G. (24S)-3β-Hydroxy-ergost-5-en-6-one from Cyttaria johowii . Phytochemistry 1994; 36: 459-461
  CrossrefPubMedGoogle Scholar
• 16 Christophoridou S, Dais P, Tseng LH, Spraul M. Separation and identification of phenolic compounds in olive oil by coupling high-perfomance liquid chromatography with postcolumn solid phase extraction to nuclear magnetic resonance spectroscopy (LC-SPE-NMR). J Agric Food Chem 2005; 53: 4667-4679
  CrossrefPubMedGoogle Scholar
• 17 Economides C, Adam KP. Lipophilic flavonoids from the fern Woodsia scopunina . Phytochemistry 1998; 49: 859-862
  CrossrefPubMedGoogle Scholar
• 18 Fujita KI, Nagamine Y, Ping X, Taniguchi M. Mode of action of anhydrofulvic acid against Candida utilis ATCC 42402 under acidic conditions. J Antibiot 1999; 52: 628-634
  CrossrefPubMedGoogle Scholar
• 19 Lösgen S, Schlörke O, Meindl K, Herbst-Irmer R, Zeeck A. Structure and biosynthesis of chaetocyclinones, new polyketides produced by an endosymbiotic fungus. Eur J Org Chem 2007; 13: 2191-2196
  PubMedGoogle Scholar
• 20 Li E, Zhang F, Niu S, Liu X, Liu X, Che Y. A spiro[chroman-3,7′-isochromene]-4,6′(8′H)-dione from the Cordyceps-colonizing fungus Fimetariella sp . Org Lett 2012; 14: 3320-3323
  CrossrefPubMedGoogle Scholar
• 21 Kapferer T, Brückner R. Asymmentric dihydroxylation of β,γ-unsaturated carboxylic esters with trisubstituted C=C bonds – enantioselective syntheses of trisubstituted γ-butyrolactones. Eur J Org Chem 2006; 9: 2119-2133
  PubMedGoogle Scholar
• 22 Ross RA, Gibson TM, Stevenson LA, Saha B, Crocker P, Razdan RK, Pertwee RG. Structural determinants of the partial agonist-inverse agonist properties of 6′-azidohex-2′-yne-Δ8-tetrahydrocannabinol at cannabinoid receptors. Br J Pharmacol 1999; 128: 735-743
  CrossrefPubMedGoogle Scholar
• 23 Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG. Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol 2005; 146: 917-926
  CrossrefPubMedGoogle Scholar
• 24 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
  CrossrefPubMedGoogle Scholar

• Supplementary Material